Urinary nucleosides as biological markers for patients with colorectal cancer

National Chromatographic R and A Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, Liaoning Province, China.
World Journal of Gastroenterology (Impact Factor: 2.37). 08/2005; 11(25):3871-6.
Source: PubMed


Fourteen urinary nucleosides, primary degradation products of tRNA, were evaluated to know the potential as biological markers for patients with colorectal cancer.
The concentrations of 14 kinds of urinary nucleosides from 52 patients with colorectal cancer, 10 patients with intestinal villous adenoma and 60 healthy adults were determined by column switching high performance liquid chromatography method.
The mean levels of 12 kinds of urinary nucleosides (except uridine and guanosine) in the patients with colorectal cancer were significantly higher than those in patients with intestinal villous adenoma or the healthy adults. Using the levels of 14 kinds of urinary nucleosides as the data vectors for principal component analysis, 71% (37/52) patients with colorectal cancer were correctly classified from healthy adults, in which the identification rate was much higher than that of CEA method (29%). Only 10% (1/10) of patients with intestinal villous adenoma were indistinguishable from patients with colorectal cancer. The levels of m1G, Pseu and m1A were positively related with tumor size and Duke's stages of colorectal cancer. When monitoring the changes in urinary nucleoside concentrations of patients with colorectal cancer associated with surgery, it was found that the overall correlations with clinical assessment were 84% (27/32) and 91% (10/11) in response group and progressive group, respectively.
These findings indicate that urinary nucleosides determined by column switching high performance liquid chromatography method may be useful as biological markers for colorectal cancer.

Download full-text


Available from: Jun Yang
  • Source
    • "This process is not, however , dependent on age among adults [17]. Therefore, according to numerous studies, urinary nucleosides have been proposed as possible cancer markers in colorectal [18] [19] [20], breast [21] [22] [23] [24] [25] [26], bladder [27] [28] [29], lymphoma [30] [31], thyroid [32] and cervical cancer [33]. So far, several analytical techniques have been applied for nucleosides' determination, including immunoassay [34], capillary electrophoresis (CE) [35] and high performance liquid chromatography (HPLC) [36]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Nucleosides, the RNA metabolites, are well known as potential markers in various types of cancer. They are mainly detected in urine wherein their concentrations were found elevated in cancer patients. In order to determine the nucleosides' profile in urine with satisfactory sensitivity and accuracy, advanced analytical techniques should be applied involving mass spectrometry detection. In this work we overviewed actual possibilities in targeted and untargeted metabolomics studies of nucleosides and their analogues (cis-diol metabolites) using high performance liquid chromatography hyphenated with mass spectrometry detection. We focused on challenges and drawbacks using different types of ion sources and analyzers. The nucleosides' fragmentation patterns were also compared for the sake of their identification in biological samples. As applied analytical techniques allow for the metabolites' determination, statistical approach essential for evaluation of nucleosides as cancer markers was also reviewed.
    Full-text · Article · May 2014 · Journal of Pharmaceutical and Biomedical Analysis
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Prostate cancer is one of the most common types of cancer in men. It is though extremely important to search for specific markers including metabolites, which concentration in blood could be a diagnostic measure. In this regard, the metabolite profiling of blood plasma was performed with two groups of people: healthy volunteers (n=30) and patients with prostate cancer, second stage (n=40). The profiling protocol included proteins removal from blood plasma with methanol and direct analysis of metabolite fractions by mass spectrometry. Identification of the most abundant metabolites in samples was performed using an accurate mass tag and an isotope pattern methods. Cancer-specific metabolites were revealed by statistical analysis of metabolite intensities in the mass spectra. Six different metabolites were found to be cancer-specific. Two metabolites, acylcarnitine and arachidonoyl amine, have the AUC 0.97 and 0.86, respectively, which are higher than those from PSA test, 0.59. KeywordsMass spectrometry-Prostate cancer-Blood plasma metabolites
    Full-text · Article · Mar 2009 · Metabolomics
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nucleosides are an important class of metabolites and have been investigated as potential tumor biomarkers. A method based on ultra peerformance liquid chromatography (UPLC)-TOF MS was developed to analyze urinary nucleosides and other metabolites with cis-diol structure to distinguish between cancer patients and healthy persons and compare the results with those obtained by HPLC. The data showed that the UPLC method used about one third of the time required by HPLC and achieved a much better chromatographic resolution and increased sensitivity, the number of peaks detected by UV being 79 and 94 for HPLC and UPLC, respectively. With UPLC-TOF MS, more information was obtained about metabolites, the separation of cancer patients from healthy persons was significantly improved, and more potential biomarkers were found. The method based on UPLC-TOF MS is a powerful technique for the study of metabolite profiles.
    No preview · Article · Nov 2006 · Journal of Separation Science
Show more